Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Naratriptan approved in 10 additional European countries

July 23, 1997

Schering AG describes AMPA antagonists

July 23, 1997

Toray/Daiichi codevelop analgesic

July 22, 1997

Maternal infection associated with increased risk for cerebral palsy in term infants

July 22, 1997

CoCensys to copromote Zarontin for pediatric epilepsy

July 21, 1997

VA-045 ameliorates head injury-induced neurological dysfunction

July 21, 1997

First report of kappa-opioid agonist efficacy in humans

July 21, 1997

FDA clears new indication and new labeling for Zoloft

July 18, 1997

New treatment options for ALS

July 18, 1997

BDNF shows potential for stroke therapy in rat model

July 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...